- Home
- AGFY vs BNR Comparison
AGFY vs BNR Comparison
Compare AGFY & BNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AGFY
- BNR
- Stock Information
- Founded
- AGFY 2016
- BNR 2014
- Country
- AGFY United States
- BNR China
- Employees
- AGFY N/A
- BNR N/A
- Industry
- AGFY Military/Government/Technical
- BNR Medical Specialities
- Sector
- AGFY Consumer Discretionary
- BNR Health Care
- Exchange
- AGFY Nasdaq
- BNR Nasdaq
- Market Cap
- AGFY 41.3M
- BNR 38.3M
- IPO Year
- AGFY 2021
- BNR 2020
- Fundamental
- Price
- AGFY $25.43
- BNR $6.80
- Analyst Decision
- AGFY
- BNR
- Analyst Count
- AGFY 0
- BNR 0
- Target Price
- AGFY N/A
- BNR N/A
- AVG Volume (30 Days)
- AGFY 16.2K
- BNR 52.8K
- Earning Date
- AGFY 08-13-2025
- BNR 08-21-2025
- Dividend Yield
- AGFY N/A
- BNR N/A
- EPS Growth
- AGFY N/A
- BNR N/A
- EPS
- AGFY N/A
- BNR N/A
- Revenue
- AGFY $10,218,000.00
- BNR $72,112,038.00
- Revenue This Year
- AGFY N/A
- BNR $136.32
- Revenue Next Year
- AGFY N/A
- BNR N/A
- P/E Ratio
- AGFY N/A
- BNR N/A
- Revenue Growth
- AGFY 9.42
- BNR 0.53
- 52 Week Low
- AGFY $2.71
- BNR $2.18
- 52 Week High
- AGFY $84.44
- BNR $9.48
- Technical
- Relative Strength Index (RSI)
- AGFY 52.51
- BNR 67.23
- Support Level
- AGFY $24.11
- BNR $4.47
- Resistance Level
- AGFY $29.34
- BNR $9.48
- Average True Range (ATR)
- AGFY 1.90
- BNR 0.74
- MACD
- AGFY 0.21
- BNR 0.36
- Stochastic Oscillator
- AGFY 37.03
- BNR 55.11
About AGFY Agrify Corporation
Agrify Corp is a developer of branded inventive solutions for the cannabis and hemp industries. Its Senorita brand offers consumers hemp-derived tetrahydrocannabinol (THC) beverages that mirror cocktails like a margarita - in three flavors - classic Lime Jalapeno Margarita, Mango Margarita, and Paloma. In addition to beverages, Agrify has also historically been a provider of inventive cultivation and extraction solutions for the cannabis industry. Its comprehensive extraction product line, which includes hydrocarbon, alcohol, solventless, post-processing, and lab equipment, empowers producers to maximize the quantity and quality of extract required for premium concentrates.
About BNR Burning Rock Biotech Limited
Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through company's in-hospital model and smaller hospitals through its central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.